Literature DB >> 16750665

Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells.

Elizabeth Fragopoulou1, Christos Iatrou, Smaragdi Antonopoulou, Xiong-Zhong Ruan, Ray L Fernando, Stephen H Powis, John F Moorhead, Zac Varghese.   

Abstract

Intra- and extracellular lipid accumulation and the production of inflammatory mediators by renal and accessory cells may play an important role in the initiation and progression of these lesions. Platelet activating factor (PAF) is a biologically active phospholipid that is produced by various cells upon activation by different stimuli. It has been suggested that PAF plays a role in atherogenesis, and several studies indicated its participation in the pathogenesis of renal diseases. The aim of this study is to investigate the role of PAF on intracellular lipid accumulation and gene regulation of lipoprotein receptors in human mesangial cells (HMCs). A human mesangial cell line (HMC) was used to study the effects of PAF on foam cell formation by Oil red O staining and on the expression of LDLr, SR-AI, and PAF-R mRNA using RT-PCR. Native LDL caused foam cell formation in HMC in the presence of PAF. PAF enhanced LDLr expression and overrode LDL receptor suppression induced by a high concentration of LDL. Moreover, it enhanced SR-AI expression. PAF also caused increase in PAF-R expression. The above data suggest that PAF enhances its own receptor expression and then increases lipid accumulation by dysregulating LDL receptor regulation and inducing scavenger receptor expression in HMCs. These results suggest that PAF has a potential role in lipid mediated renal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750665     DOI: 10.1016/j.lab.2006.01.004

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

Review 1.  The role of platelet-activating factor in mesangial pathophysiology.

Authors:  Anna Reznichenko; Ron Korstanje
Journal:  Am J Pathol       Date:  2015-02-02       Impact factor: 4.307

Review 2.  Therapy for acute pancreatitis with platelet-activating factor receptor antagonists.

Authors:  Chong Chen; Shi-Hai Xia; Hong Chen; Xiao-Hong Li
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

3.  Atorvastatin prevents glomerular extracellular matrix formation by interfering with the PKC signaling pathway.

Authors:  Yan-Hua Xiao; Xiao-Yun He; Qing Han; Fan Yang; Su-Xian Zhou
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

4.  Altered gene expression in antipsychotic-induced weight gain.

Authors:  Benedicto Crespo-Facorro; Carlos Prieto; Jesus Sainz
Journal:  NPJ Schizophr       Date:  2019-04-10

Review 5.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.